**Stelara: Effective October 15th, Stelara SQ is no longer covered under Medicare Part B in New York.
Specialty Infusion is able to service Medicare patients using Medicare Part D benefits through QuickRx Pharmacy. E-prescribe at (347) 691 – 3494.
STELARA SQ® (Ustekinumab) is an immunosuppressive drug that reduces inflammation in the body due to various autoimmune diseases.
STELARA SQ® is manufactured by Janssen Biotech.
Administration and Dosage:
For patients with Crohn’s disease, administration of STELARA is a regimen 1 intravenous infusion therapy followed by a maintenance dose of subcutaneous injections every 8 weeks. Patients with Plaque Psoriasis and Psoriatic Arthritis, STELARA is administred subcutaneously at week 1 and then week 4, followed by every 12 weeks regimen.
Common Side Effects:
The more common side effects of STELARA SQ® include serious infections, which may require hospitalization, including tuberculosis (TB), and infections caused by bacteria, fungi, or viruses.
More Information:
Please read the full Prescribing Information and Medication Guide for STELARA SQ® and discuss any questions you have with your doctor.
Ready to Schedule an Appointment?
Please CLICK HERE to get started.
Indication:
STELARA SQ® is indicated to treat:
- Crohn’s Disease
- Plaque Psoriasis
- Psoriatic Arthritis
